Analysts fell to the sidelines weighing in on Staar Surgical Company (STAA – Research Report) and Abbott Labs (ABT – Research Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks.
Staar Surgical Company (STAA)
In a report released today, Ryan Zimmerman from BTIG upgraded Staar Surgical Company to Hold. The company’s shares closed last Tuesday at $69.30.
According to TipRanks.com, Zimmerman is a 5-star analyst with an average return of 13.2% and a 57.5% success rate. Zimmerman covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Zimmer Biomet Holdings, and Integra Lifesciences.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Staar Surgical Company with a $65.00 average price target.
Abbott Labs (ABT)
In a report released today, Marie Thibault from BTIG maintained a Hold rating on Abbott Labs. The company’s shares closed last Tuesday at $108.97, close to its 52-week high of $114.20.
According to TipRanks.com, Thibault is a 5-star analyst with an average return of 29.5% and a 57.4% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings, Varian Medical Systems, and Edwards Lifesciences.
Currently, the analyst consensus on Abbott Labs is a Strong Buy with an average price target of $119.82.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.